Schroder Investment Management Group
TDOC icon

Schroder Investment Management Group’s Teladoc Health TDOC Stock Holding History

Schroder Investment Management Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-37,025
Closed -$559K – 1261
2024
Q1 		$559K Buy
37,025
+12,909
+54% +$234K ﹤0.01% 1098
2023
Q4 		$532K Hold
24,116
– – ﹤0.01% 1087
2023
Q3 		$447K Buy
24,116
+23,516
+3,919% +$549K ﹤0.01% 1112
2023
Q2 		$15.2K Buy
600
+64
+12% +$1.61K ﹤0.01% 1215
2023
Q1 		$13.1K Buy
536
+436
+436% +$11.7K ﹤0.01% 1248
2022
Q4 		$2.38K Buy
+100
New +$2.7K ﹤0.01% 1274
2022
Q3 		– Sell
-2,402
Closed -$80K – 1345
2022
Q2 		$80K Sell
2,402
-61,313
-96% -$2.6M ﹤0.01% 1293
2022
Q1 		$4.66M Buy
63,715
+16,620
+35% +$1.2M 0.01% 859
2021
Q4 		$4.32M Buy
47,095
+9,209
+24% +$1.1M 0.01% 790
2021
Q3 		$4.8M Buy
37,886
+2,968
+8% +$432K 0.01% 796
2021
Q2 		$5.81M Sell
34,918
-6,612
-16% -$1.07M 0.01% 799
2021
Q1 		$7.55M Sell
41,530
-14,977
-27% -$3.47M 0.01% 726
2020
Q4 		$11.3M Buy
56,507
+28,305
+100% +$5.76M 0.02% 599
2020
Q3 		$6.25M Buy
28,202
+3,154
+13% +$668K 0.01% 687
2020
Q2 		$4.78M Sell
25,048
-100,976
-80% -$17.7M 0.01% 680
2020
Q1 		$18.9M Sell
126,024
-125,100
-50% -$14.6M 0.04% 387
2019
Q4 		$21M Buy
251,124
+9,951
+4% +$757K 0.03% 483
2019
Q3 		$16M Sell
241,173
-248,923
-51% -$16.4M 0.03% 501
2019
Q2 		$32.5M Buy
490,096
+279,602
+133% +$16.3M 0.02% 501
2019
Q1 		$11.7M Buy
210,494
+2,243
+1% +$137K 0.02% 555
2018
Q4 		$10.3M Buy
208,251
+128,639
+162% +$7.87M 0.02% 544
2018
Q3 		$6.87M Sell
79,612
-54,504
-41% -$3.88M 0.01% 655
2018
Q2 		$7.74M Sell
134,116
-55,714
-29% -$2.72M 0.01% 640
2018
Q1 		$7.65M Sell
189,830
-4,020
-2% -$152K 0.01% 660
2017
Q4 		$6.76M Sell
193,850
-166,364
-46% -$5.52M 0.01% 724
2017
Q3 		$11.8M Sell
360,214
-10,682
-3% -$350K 0.02% 594
2017
Q2 		$13.1M Sell
370,896
-65,897
-15% -$1.92M 0.02% 555
2017
Q1 		$11M Buy
+436,793
New +$9.09M 0.02% 592

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Schroder Investment Management Group's TDOC Position: Q2 2024 in Review

Schroder Investment Management Group sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 37,025 shares — an estimated $559K sold.

Schroder Investment Management Group first reported a position in TDOC in Q1 2017 and held it in 28 quarters. The position peaked at $32.5M in Q2 2019. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Schroder Investment Management Group reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Schroder Investment Management Group sold 37,025 Teladoc Health shares in Q2 2024, an estimated $559K.
  • Schroder Investment Management Group first reported a position in Teladoc Health in Q1 2017 and held it in 28 quarters.
  • Schroder Investment Management Group's Teladoc Health position peaked at $32.5M in Q2 2019.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Schroder Investment Management Group's 13F filing for Q2 2024, filed 12 Aug 2024.